#Cannabis, #Biotech, #China
and #Mining #Stocks added to Investor Ideas
and #Mining #Stocks added to Investor Ideas
Point Roberts, WA, Delta BC – August 31, 2018 –
(Investorideas.com Newswire) Investorideas.com, a global news source and
leading investor resource covering actively traded sectors announces this
week’s additions to its global stock
directories in cannabis, biotech, China-Asia and mining.
(Investorideas.com Newswire) Investorideas.com, a global news source and
leading investor resource covering actively traded sectors announces this
week’s additions to its global stock
directories in cannabis, biotech, China-Asia and mining.
Investorideas.com tracks companies in high-profile
trading sectors and makes ongoing additions to its stock directories for its members. Free previews of all
directories are available to the public with full login access only accessible
to members.
trading sectors and makes ongoing additions to its stock directories for its members. Free previews of all
directories are available to the public with full login access only accessible
to members.
Read this in full at https://www.investorideas.com/news/2018/main/08311Stocks.asp
The newest cannabis companies are involved in
hemp-based CBD products and medical cannabis respectively.
hemp-based CBD products and medical cannabis respectively.
The latest biotech companies include a medical
device company, a gene therapy company and a pharma company involved in developing anti-infectives.
device company, a gene therapy company and a pharma company involved in developing anti-infectives.
New China-Asia companies are involved in the
education and IT-Fintech sectors. The
newest mining company is working in Mexico at the Rebeico Gold-Copper project.
education and IT-Fintech sectors. The
newest mining company is working in Mexico at the Rebeico Gold-Copper project.
New Cannabis Companies:
Charlotte's Web Holdings, Inc. (CSE: CWEB) is a market
leader in the production and distribution of innovative hemp-based, CBD
wellness products. Through its vertically integrated business model,
CWEB strives to improve customers’ lives and meet their demands for
stringent product quality, efficacy and consistency.
leader in the production and distribution of innovative hemp-based, CBD
wellness products. Through its vertically integrated business model,
CWEB strives to improve customers’ lives and meet their demands for
stringent product quality, efficacy and consistency.
Pure Global Cannabis Inc. (TSX:PURE.V; OTC: PRCNF) is a vertically-integrated, growth-oriented life sciences
cannabis company led by experienced pharma-industry, horticultural, consumer
packaged goods (CPG), and supply chain experts. The Company's wholly owned
subsidiary, PureSinse Inc., is a licensed producer under the Access to Cannabis
for Medical Purposes Regulations (ACMPR) focused on producing cannabis products
for medical, wellness, health & beauty, natural health, and future legal
adult use markets.
cannabis company led by experienced pharma-industry, horticultural, consumer
packaged goods (CPG), and supply chain experts. The Company's wholly owned
subsidiary, PureSinse Inc., is a licensed producer under the Access to Cannabis
for Medical Purposes Regulations (ACMPR) focused on producing cannabis products
for medical, wellness, health & beauty, natural health, and future legal
adult use markets.
Investorideas.com
cannabis/marijuana and hemp news and investing content now includes our daily potcastsCM ; podcasts featuring cannabis news and stocks to watch plus
insight from thought leaders and experts. Recent
interviews include Montel Williams, The Arcview Group, Electrum Partners and
the CEO of Cronos Group Inc. (NASDAQ: CRON).
cannabis/marijuana and hemp news and investing content now includes our daily potcastsCM ; podcasts featuring cannabis news and stocks to watch plus
insight from thought leaders and experts. Recent
interviews include Montel Williams, The Arcview Group, Electrum Partners and
the CEO of Cronos Group Inc. (NASDAQ: CRON).
The cannabis stocks potcast (podcast)
is also released with an accompanying written transcript. Learn more and sign up at http://www.investorideas.com/Audio/Potcasts.aspOr www.potcasts.ca
is also released with an accompanying written transcript. Learn more and sign up at http://www.investorideas.com/Audio/Potcasts.aspOr www.potcasts.ca
To sponsor our daily podcast for the month or to be an expert guest
please contact us!
please contact us!
New Biotech Companies
Hancock
Jaffe Laboratories, Inc. (NasdaqCM:HJLI) specializes in developing and manufacturing bioprosthetic medical
devices that establish improved standards of care for treating cardiac and
vascular diseases. HJLI currently has three product candidates: the porcine
tissue based VenoValve®, which is intended to be surgically implanted in the
deep venous system of the leg to treat Chronic Venue Insufficiency; the
CoreoGraft®, a bovine tissue based off the shelf conduit intended to be used
for coronary artery bypass surgery, and a porcine tissue based heart valve,
which based upon its relatively small size and increased output, is an ideal
candidate for pediatric aortic/mitral valve replacement.
Jaffe Laboratories, Inc. (NasdaqCM:HJLI) specializes in developing and manufacturing bioprosthetic medical
devices that establish improved standards of care for treating cardiac and
vascular diseases. HJLI currently has three product candidates: the porcine
tissue based VenoValve®, which is intended to be surgically implanted in the
deep venous system of the leg to treat Chronic Venue Insufficiency; the
CoreoGraft®, a bovine tissue based off the shelf conduit intended to be used
for coronary artery bypass surgery, and a porcine tissue based heart valve,
which based upon its relatively small size and increased output, is an ideal
candidate for pediatric aortic/mitral valve replacement.
Iterum
Therapeutics plc (NasdaqGM:ITRM) is a clinical-stage pharmaceutical company
dedicated to developing differentiated anti-infectives aimed at combatting the
global crisis of multi-drug resistant pathogens to significantly improve the
lives of people affected by serious and life-threatening diseases around the
world. Iterum Therapeutics is advancing its first compound, sulopenem, a novel
penem anti-infective compound with oral and IV formulations that has
demonstrated potent in vitro activity against a wide variety of gram-negative,
gram-positive and anaerobic bacteria resistant to other antibiotics. Iterum
Therapeutics has received QIDP designations for its oral and IV formulations
for the treatment of uUTI, complicated urinary tract infection and complicated
intra-abdominal infection.
Therapeutics plc (NasdaqGM:ITRM) is a clinical-stage pharmaceutical company
dedicated to developing differentiated anti-infectives aimed at combatting the
global crisis of multi-drug resistant pathogens to significantly improve the
lives of people affected by serious and life-threatening diseases around the
world. Iterum Therapeutics is advancing its first compound, sulopenem, a novel
penem anti-infective compound with oral and IV formulations that has
demonstrated potent in vitro activity against a wide variety of gram-negative,
gram-positive and anaerobic bacteria resistant to other antibiotics. Iterum
Therapeutics has received QIDP designations for its oral and IV formulations
for the treatment of uUTI, complicated urinary tract infection and complicated
intra-abdominal infection.
MeiraGTx
Holdings plc (NasdaqGS:MGTX) is a vertically integrated, clinical stage gene
therapy company with four ongoing clinical programs and a broad pipeline of
preclinical and research programs. MeiraGTx has core capabilities in viral
vector design and optimization and gene therapy manufacturing, as well as a
potentially transformative gene regulation technology. Led by an experienced
management team, MeiraGTx has taken a portfolio approach by licensing, acquiring
and developing technologies that give depth across both product candidates and
indications. MeiraGTx’s initial focus is on three distinct areas of unmet
medical need: inherited retinal diseases, severe forms of xerostomia and
neurodegenerative diseases. Though initially focusing on the eye, salivary
gland and central nervous system, MeiraGTx intends to expand its focus in the
future to develop additional gene therapy treatments for patients suffering
from a range of serious diseases.
Holdings plc (NasdaqGS:MGTX) is a vertically integrated, clinical stage gene
therapy company with four ongoing clinical programs and a broad pipeline of
preclinical and research programs. MeiraGTx has core capabilities in viral
vector design and optimization and gene therapy manufacturing, as well as a
potentially transformative gene regulation technology. Led by an experienced
management team, MeiraGTx has taken a portfolio approach by licensing, acquiring
and developing technologies that give depth across both product candidates and
indications. MeiraGTx’s initial focus is on three distinct areas of unmet
medical need: inherited retinal diseases, severe forms of xerostomia and
neurodegenerative diseases. Though initially focusing on the eye, salivary
gland and central nervous system, MeiraGTx intends to expand its focus in the
future to develop additional gene therapy treatments for patients suffering
from a range of serious diseases.
New China-Asia Companies
Ambow Education Holding Ltd. (NYSE:AMBO) is a leading national provider of educational and
career enhancement services in China, offering high-quality, individualized
services and products. With its extensive network of regional service hubs
complemented by a dynamic proprietary learning platform and distributors, Ambow
provides its services and products to students in 30 out of the 31 provinces
and autonomous regions within China.
career enhancement services in China, offering high-quality, individualized
services and products. With its extensive network of regional service hubs
complemented by a dynamic proprietary learning platform and distributors, Ambow
provides its services and products to students in 30 out of the 31 provinces
and autonomous regions within China.
CLPS Incorporation (NasdaqCM: CLPS)
is a global leading information technology ("IT"), consulting and
solutions service provider focusing on the banking, insurance and financial
sectors. The Company serves as an IT solutions provider to a growing network of
clients in the global financial industry, including large financial institutions
in the US, Europe, Australia and Hong Kong and their PRC-based IT centers. The
Company maintains eleven delivery and/or research & development centers to
serve different customers in various geographic locations. Mainland China
centers are located in Shanghai, Beijing, Dalian, Tianjin, Chengdu, Guangzhou
and Shenzhen. The remaining four global centers are located in Hong Kong,
Taiwan, Singapore and Australia.
is a global leading information technology ("IT"), consulting and
solutions service provider focusing on the banking, insurance and financial
sectors. The Company serves as an IT solutions provider to a growing network of
clients in the global financial industry, including large financial institutions
in the US, Europe, Australia and Hong Kong and their PRC-based IT centers. The
Company maintains eleven delivery and/or research & development centers to
serve different customers in various geographic locations. Mainland China
centers are located in Shanghai, Beijing, Dalian, Tianjin, Chengdu, Guangzhou
and Shenzhen. The remaining four global centers are located in Hong Kong,
Taiwan, Singapore and Australia.
New Mining Companies
Ridgestone
Mining Inc. (TSX:RMI.V) is a TSX Venture Exchange -listed junior mineral
exploration company with offices in Taipei and Vancouver, B.C. The Company's
focus is on precious metals and copper in Sonora, Mexico, and specifically the
Rebeico Gold-Copper project.
Mining Inc. (TSX:RMI.V) is a TSX Venture Exchange -listed junior mineral
exploration company with offices in Taipei and Vancouver, B.C. The Company's
focus is on precious metals and copper in Sonora, Mexico, and specifically the
Rebeico Gold-Copper project.
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
but as a research tool to discover opportunities and trading ideas in a
particular sector.
Membership: Investorideas.com stock directories are part of the
membership program on the site, accessed either by login and password or
available in PDF format. The directories include stocks trading on the
TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving
retail investors a wide variety of stocks to review.
membership program on the site, accessed either by login and password or
available in PDF format. The directories include stocks trading on the
TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving
retail investors a wide variety of stocks to review.
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a
recognized news source publishing third party news and press releases plus we
create original financial content. Learn about investing in stocks and
sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking
about cannabis, crypto, technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor
Ideas #Potcasts
#Cannabis News and Stocks on the Move podcast and column, Cleantech and
Climate Change Podcast and the Stock Guru daily podcast on Support and
Resistance Trading.
recognized news source publishing third party news and press releases plus we
create original financial content. Learn about investing in stocks and
sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking
about cannabis, crypto, technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor
Ideas #Potcasts
#Cannabis News and Stocks on the Move podcast and column, Cleantech and
Climate Change Podcast and the Stock Guru daily podcast on Support and
Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer and disclosure info: http://www.investorideas.com/About/Disclaimer.asp.
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer and disclosure info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding
BC Residents and global Investors: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
BC Residents and global Investors: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Learn more about our news, PR and social media
services at Investorideas.com
services at Investorideas.com
To sponsor one of our
podcasts or columns or be a guest call us today!
podcasts or columns or be a guest call us today!
Contact
Investorideas.com
Investorideas.com
800-665-0411
